Qube Research & Technologies LTD Senseonics Holdings, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 51,942 shares of SENS stock, worth $19,218. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,942
Previous 135,114
61.56%
Holding current value
$19,218
Previous $71,000
71.83%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SENS
# of Institutions
141Shares Held
59.5MCall Options Held
413KPut Options Held
212K-
Vanguard Group Inc Valley Forge, PA23.2MShares$8.58 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$3.08 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA7MShares$2.59 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA5.66MShares$2.09 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.11MShares$1.15 Million0.0% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $172M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...